mTOR and metabolic regulation of conventional and regulatory t cells

Journal of Leukocyte Biology

Volumn 97, Issue 5, 2015, Pages 837-847

  Liu, Chaohong ^a   Chapman, Nicole M ^a   Karmaus, Peer W F ^a   Zeng, Hu ^a   Chi, Hongbo ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Glycolysis; Lipid; Metabolism; T cell differentiation; Tregs

Indexed keywords

ADAPTOR PROTEIN; CD28 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1;

ADAPTIVE IMMUNITY; AMINO ACID TRANSPORT; CELL DIFFERENTIATION; CELL MATURATION; GLUCOSE METABOLISM; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; METABOLIC REGULATION; METABOLISM; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84929176416     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.2RI0814-408R     Document Type: Review

References (118)

1. Chi, H. (2012) Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12, 325–338.
2. Laplante, M., Sabatini, D. M. (2012) mTOR signaling in growth control and disease. Cell 149, 274–293.
3. Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., Vander Heiden, M. G., MacKeigan, J. P., Finan, P. M., Clish, C. B., Murphy, L. O., Manning, B. D. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex1. Mol. Cell 39, 171–183.
4. Powell, J. D., Pollizzi, K. N., Heikamp, E. B., Horton, M. R. (2012) Regulation of immune responses by mTOR. Annu. Rev. Immunol. 30, 39–68.
5. Brennan, P. J., Brigl, M., Brenner, M. B. (2013) Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13, 101–117.
6. Josefowicz, S. Z., Lu, L. F., Rudensky, A. Y. (2012) Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–564.
7. Abbas, A. K., Benoist, C., Bluestone, J. A., Campbell, D. J., Ghosh, S., Hori, S., Jiang, S., Kuchroo, V. K., Mathis, D., Roncarolo, M. G., Rudensky, A., Sakaguchi, S., Shevach, E. M., Vignali, D. A., Ziegler, S. F. (2013) Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14, 307–308.
8. Brownlie, R. J., Zamoyska, R. (2013) T Cell receptor signalling networks: branched, diversified and bounded. Nat. Rev. Immunol. 13, 257–269.
9. Park, S. G., Schulze-Luehrman, J., Hayden, M. S., Hashimoto, N., Ogawa, W., Kasuga, M., Ghosh, S. (2009) The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells. Nat. Immunol. 10, 158–166.
10. Dan, H. C., Ebbs, A., Pasparakis, M., Van Dyke, T., Basseres, D. S., Baldwin, A. S. (2014) Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IkB kinase a (IKKa). J. Biol. Chem. 289, 25227–25240.
11. Vander Haar, E., Lee, S. I., Bandhakavi, S., Griffin, T. J., Kim, D. H. (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9, 316–323.
12. Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., Cantrell, D. A. (2012) PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441–2453.
13. Macintyre, A. N., Finlay, D., Preston, G., Sinclair, L. V., Waugh, C. M., Tamas, P., Feijoo, C., Okkenhaug, K., Cantrell, D. A. (2011) Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 34, 224–236.
14. Delgoffe, G. M., Kole, T. P., Cotter, R. J., Powell, J. D. (2009) Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. Mol. Immunol. 46, 2694–2698.
15. Hamilton, K. S., Phong, B., Corey, C., Cheng, J., Gorentla, B., Zhong, X., Shiva, S., Kane, L. P. (2014) T Cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10. Sci. Signal. 7-55.
16. Nakaya, M., Xiao, Y., Zhou, X., Chang, J. H., Chang, M., Cheng, X., Blonska, M., Lin, X., Sun, S. C. (2014) Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40, 692–705.
17. Sinclair, L. V., Rolf, J., Emslie, E., Shi, Y. B., Taylor, P. M., Cantrell, D. A. (2013) Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14, 500–508.
18. Efeyan, A., Zoncu, R., Sabatini, D. M. (2012) Amino acids and mTORC1: from lysosomes to disease. Trends Mol. Med. 18, 524–533.
19. Jewell, J. L., Russell, R. C., Guan, K. L. (2013) Amino acid signalling upstream of mTOR. Nat. Rev. Mol. Cell Biol. 14, 133–139.
20. Yang, K., Neale, G., Green, D. R., He, W., Chi, H. (2011) The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat. Immunol. 12, 888–897.
21. Yang, K., Shrestha, S., Zeng, H., Karmaus, P. W., Neale, G., Vogel, P., Guertin, D. A., Lamb, R. F., Chi, H. (2013) T Cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1- mediated metabolic reprogramming. Immunity 39, 1043–1056.
22. Zhong, X. P., Guo, R., Zhou, H., Liu, C., Wan, C. K. (2008) Diacylglycerol kinases in immune cell function and self-tolerance. Immunol. Rev. 224, 249–264.
23. Mérida, I., Avila-Flores, A., Merino, E. (2008) Diacylglycerol kinases: at the hub of cell signalling. Biochem. J. 409, 1–18.
24. Gorentla, B. K., Wan, C. K., Zhong, X. P. (2011) Negative regulation of mTOR activation by diacylglycerol kinases. Blood 117, 4022–4031.
25. Ananieva, E. A., Patel, C. H., Drake, C. H., Powell, J. D., Hutson, S. M. (2014) Cytosolic branched chain aminotransferase (BCATc) regulates mTORC1 signaling and glycolytic metabolism in CD4+ T cells. J. Biol. Chem. 289, 18793–18804.
26. Rochman, Y., Spolski, R., Leonard, W. J. (2009) New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9, 480–490.
27. Rathmell, J. C., Farkash, E. A., Gao, W., Thompson, C. B. (2001) IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167, 6869–6876.
28. Wofford, J. A., Wieman, H. L., Jacobs, S. R., Zhao, Y., Rathmell, J. C. (2008) IL-7 promotes Glut1 trafficking and glucose uptake via STAT5- mediated activation of Akt to support T-cell survival. Blood 111, 2101–2111.
29. Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., Brasel, K., Morrissey, P. J., Stocking, K., Schuh, J. C., Joyce, S., Peschon, J. J. (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771–780.
30. Li, Q., Rao, R. R., Araki, K., Pollizzi, K., Odunsi, K., Powell, J. D., Shrikant, P. A. (2011) A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. Immunity 34, 541–553.
31. Gomez-Rodriguez, J., Wohlfert, E. A., Handon, R., Meylan, F., Wu, J. Z., Anderson, S. M., Kirby, M. R., Belkaid, Y., Schwartzberg, P. L. (2014) Itkmediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. J. Exp. Med. 211, 529–543.
32. Zeng, H., Yang, K., Cloer, C., Neale, G., Vogel, P., Chi, H. (2013) mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499, 485–490.
33. Kaech, S. M., Cui, W. (2012) Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749–761.
34. Rao, R. R., Li, Q., Odunsi, K., Shrikant, P. A. (2010) The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32, 67–78.
35. Stephenson, L. M., Park, D. S., Mora, A. L., Goenka, S., Boothby, M. (2005) Sequence motifs in IL-4R alpha mediating cell-cycle progression of primary lymphocytes. J. Immunol. 175, 5178–5185.
36. Gulen, M. F., Kang, Z., Bulek, K., Youzhong, W., Kim, T. W., Chen, Y., Altuntas, C. Z., Sass Bak-Jensen, K., McGeachy, M. J., Do, J. S., Xiao, H., Delgoffe, G. M., Min, B., Powell, J. D., Tuohy, V. K., Cua, D. J., Li, X. (2010) The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32, 54–66.
37. Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., Lechler, R. I. (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897–901.
38. Procaccini, C., De Rosa, V., Galgani, M., Carbone, F., Cassano, S., Greco, D., Qian, K., Auvinen, P., Calì, G., Stallone, G., Formisano, L., La Cava, A., Matarese, G. (2012) Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J. Immunol. 189, 2941–2953.
39. Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., Cyster, J. G. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor1. Nature 427, 355–360.
40. Allende, M. L., Dreier, J. L., Mandala, S., Proia, R. L. (2004) Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 279, 15396–15401.
41. Chi, H., Flavell, R. A. (2005) Cutting edge: regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor1. J. Immunol. 174, 2485–2488.
42. Liu, G., Yang, K., Burns, S., Shrestha, S., Chi, H. (2010) The S1P(1)- mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat. Immunol. 11, 1047–1056.
43. Hoshii, T., Kasada, A., Hatakeyama, T., Ohtani, M., Tadokoro, Y., Naka, K., Ikenoue, T., Ikawa, T., Kawamoto, H., Fehling, H. J., Araki, K., Yamamura, K., Matsuda, S., Hirao, A. (2014) Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells. Proc. Natl. Acad. Sci. USA 111, 3805–3810.
44. Lee, K., Nam, K. T., Cho, S. H., Gudapati, P., Hwang, Y., Park, D. S., Potter, R., Chen, J., Volanakis, E., Boothby, M. (2012) Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J. Exp. Med. 209, 713–728.
45. Chou, P. C., Oh, W. J., Wu, C. C., Moloughney, J., Rüegg, M. A., Hall, M. N., Jacinto, E., Werlen, G. (2014) Mammalian target of rapamycin complex 2 modulates abTCR processing and surface expression during thymocyte development. J. Immunol. 193, 1162–1170.
46. Lee, Y. J., Holzapfel, K. L., Zhu, J., Jameson, S. C., Hogquist, K. A. (2013) Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146–1154.
47. Wu, J., Yang, J., Yang, K., Wang, H., Gorentla, B., Shin, J., Qiu, Y., Que, L. G., Foster, W. M., Xia, Z., Chi, H., Zhong, X. P. (2014) iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions. J. Clin. Invest. 124, 1685–1698.
48. Shin, J., Wang, S., Deng, W., Wu, J., Gao, J., Zhong, X. P. (2014) Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function. Proc. Natl. Acad. Sci. USA 111, E776–E783.
49. Zhang, L., Tschumi, B. O., Corgnac, S., Rüegg, M. A., Hall, M. N., Mach, J. P., Romero, P., Donda, A. (2014) Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function. J. Immunol. 193, 1759–1765.
50. Wei, J., Yang, K., Chi, H. (2014) Cutting edge: discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision. J. Immunol. 193, 4297–4301.
51. Prevot, N., Pyaram, K., Bischoff, E., Sen, J. M., Powell, J. D., Chang, C. H. (2015) Mammalian target of rapamycin complex 2 regulates invariant NK T cell development and function independent of promyelocytic leukemia zinc-finger. J. Immunol. 194, 223–230.
52. Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., Green, D. R. (2011) The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871–882.
53. Pearce, E. L., Poffenberger, M. C., Chang, C. H., Jones, R. G. (2013) Fueling immunity: insights into metabolism and lymphocyte function. Science 342, 1242454.
54. MacIver, N. J., Michalek, R. D., Rathmell, J. C. (2013) Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259–283.
55. Wang, R., Green, D. R. (2012) Metabolic checkpoints in activated T cells. Nat. Immunol. 13, 907–915.
56. Wu, Q., Liu, Y., Chen, C., Ikenoue, T., Qiao, Y., Li, C. S., Li, W., Guan, K. L., Liu, Y., Zheng, P. (2011) The tuberous sclerosis complexmammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. J. Immunol. 187, 1106–1112.
57. O’Brien, T. F., Gorentla, B. K., Xie, D., Srivatsan, S., McLeod, I. X., He, Y. W., Zhong, X. P. (2011) Regulation of T-cell survival and mitochondrial homeostasis by TSC1. Eur. J. Immunol. 41, 3361–3370.
58. Liu, X., Karnell, J. L., Yin, B., Zhang, R., Zhang, J., Li, P., Choi, Y., Maltzman, J. S., Pear, W. S., Bassing, C. H., Turka, L. A. (2010) Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. J. Clin. Invest. 120, 2497–2507.
59. MacIver, N. J., Blagih, J., Saucillo, D. C., Tonelli, L., Griss, T., Rathmell, J. C., Jones, R. G. (2011) The liver kinase B1 is a central regulator of T cell development, activation, and metabolism. J. Immunol. 187, 4187–4198.
60. Tamás, P., Macintyre, A., Finlay, D., Clarke, R., Feijoo-Carnero, C., Ashworth, A., Cantrell, D. (2010) LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells. Eur. J. Immunol. 40, 242–253.
61. Thorens, B., Mueckler, M. (2010) Glucose transporters in the 21st century. Am. J. Physiol. Endocrinol. Metab. 298, E141–E145.
62. Macintyre, A. N., Gerriets, V. A., Nichols, A. G., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., Rathmell, J. C. (2014) The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20, 61–72.
63. Jacobs, S. R., Herman, C. E., Maciver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., Rathmell, J. C. (2008) Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J. Immunol. 180, 4476–4486.
64. Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., Rathmell, J. C. (2011) Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299–3303.
65. Buckley, A. F., Kuo, C. T., Leiden, J. M. (2001) Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat. Immunol. 2, 698–704.
66. Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X. Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., Thompson, C. B. (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. USA 105, 18782–18787.
67. Chou, C., Pinto, A. K., Curtis, J. D., Persaud, S. P., Cella, M., Lin, C. C., Edelson, B. T., Allen, P. M., Colonna, M., Pearce, E. L., Diamond, M. S., Egawa, T. (2014) c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8 T cells. Nat. Immunol. 15, 884–893.
68. Makino, Y., Nakamura, H., Ikeda, E., Ohnuma, K., Yamauchi, K., Yabe, Y., Poellinger, L., Okada, Y., Morimoto, C., Tanaka, H. (2003) Hypoxiainducible factor regulates survival of antigen receptor-driven T cells. J. Immunol. 171, 6534–6540.
69. Zhu, J., Yamane, H., Paul, W. E. (2010) Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28, 445–489.
70. Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., Powell, J. D. (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30, 832–844.
71. Delgoffe, G. M., Pollizzi, K. N., Waickman, A. T., Heikamp, E., Meyers, D. J., Horton, M. R., Xiao, B., Worley, P. F., Powell, J. D. (2011) The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12, 295–303.
72. Lee, K., Gudapati, P., Dragovic, S., Spencer, C., Joyce, S., Killeen, N., Magnuson, M. A., Boothby, M. (2010) Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32, 743–753.
73. Kurebayashi, Y., Nagal, S., Ikejiri, A., Ohtani, M., Ichiyama, K., Baba, Y., Egami, S., Hoshii, T., Hirao, A., Matsuda, S., Koyasu, S. (2012) PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORg. Cell Rep 1, 360–373.
74. Dang, E. V., Barbi, J., Yang, H. Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H. R., Luo, W., Zeller, K., Shimoda, L., Topalian, S. L., Semenza, G. L., Dang, C. V., Pardoll, D. M., Pan, F. (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor1. Cell 146, 772–784.
75. Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., Chi, H. (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367–1376.
76. Masopust, D., Ahmed, R. (2004) Reflections on CD8 T-cell activation and memory. Immunol. Res. 29, 151–160.
77. Zhang, N., Bevan, M. J. (2011) CD8(+) T cells: foot soldiers of the immune system. Immunity 35, 161–168.
78. Doedens, A. L., Phan, A. T., Stradner, M. H., Fujimoto, J. K., Nguyen, J. V., Yang, E., Johnson, R. S., Goldrath, A. W. (2013) Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat. Immunol. 14, 1173–1182.
79. Lukashev, D., Klebanov, B., Kojima, H., Grinberg, A., Ohta, A., Berenfeld, L., Wenger, R. H., Ohta, A., Sitkovsky, M. (2006) Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J. Immunol. 177, 4962–4965.
80. Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., Renner, K., Timischl, B., Mackensen, A., Kunz-Schughart, L., Andreesen, R., Krause, S. W., Kreutz, M. (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109, 3812–3819.
81. Shime, H., Yabu, M., Akazawa, T., Kodama, K., Matsumoto, M., Seya, T., Inoue, N. (2008) Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J. Immunol. 180, 7175–7183.
82. Yabu, M., Shime, H., Hara, H., Saito, T., Matsumoto, M., Seya, T., Akazawa, T., Inoue, N. (2011) IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid. Int. Immunol. 23, 29–41.
83. Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., Ahmed, R. (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108–112.
84. Berezhnoy, A., Castro, I., Levay, A., Malek, T. R., Gilboa, E. (2014) Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity. J. Clin. Invest. 124, 188–197.
85. Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L. S., Jones, R. G., Choi, Y. (2009) Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103–107.
86. Turner, A. P., Shaffer, V. O., Araki, K., Martens, C., Turner, P. L., Gangappa, S., Ford, M. L., Ahmed, R., Kirk, A. D., Larsen, C. P. (2011) Sirolimus enhances the magnitude and quality of viral-specific CD8+ Tcell responses to vaccinia virus vaccination in rhesus macaques. Am. J. Transplant. 11, 613–618.
87. Shrestha, S., Yang, K., Wei, J., Karmaus, P. W., Neale, G., Chi, H. (2014) Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs. Proc. Natl. Acad. Sci. USA 111, 14858–14863.
88. Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J. G., Yu, Z., Roychoudhuri, R., Palmer, D. C., Muranski, P., Karoly, E. D., Mohney, R. P., Klebanoff, C. A., Lal, A., Finkel, T., Restifo, N. P., Gattinoni, L. (2013) Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 123, 4479–4488.
89. Sowell, R. T., Rogozinska, M., Nelson, C. E., Vezys, V., Marzo, A. L. (2014) Cutting edge: generation of effector cells that localize to mucosal tissues and form resident memory CD8 T cells is controlled by mTOR. J. Immunol. 193, 2067–2071.
90. Shimobayashi, M., Hall, M. N. (2014) Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat. Rev. Mol. Cell Biol. 15, 155–162.
91. Kidani, Y., Elsaesser, H., Hock, M. B., Vergnes, L., Williams, K. J., Argus, J. P., Marbois, B. N., Komisopoulou, E., Wilson, E. B., Osborne, T. F., Graeber, T. G., Reue, K., Brooks, D. G., Bensinger, S. J. (2013) Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat. Immunol. 14, 489–499.
92. Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y. L., Schulze, A. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224–236.
93. Hagiwara, A., Cornu, M., Cybulski, N., Polak, P., Betz, C., Trapani, F., Terracciano, L., Heim, M. H., Rüegg, M. A., Hall, M. N. (2012) Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15, 725–738.
94. Yuan, M., Pino, E., Wu, L., Kacergis, M., Soukas, A. A. (2012) Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex2. J. Biol. Chem. 287, 29579–29588.
95. Park, Y., Jin, H. S., Lopez, J., Elly, C., Kim, G., Murai, M., Kronenberg, M., Liu, Y. C. (2013) TSC1 regulates the balance between effector and regulatory T cells. J. Clin. Invest. 123, 5165–5178.
96. Valmori, D., Tosello, V., Souleimanian, N. E., Godefroy, E., Scotto, L., Wang, Y., Ayyoub, M. (2006) Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J. Immunol. 177, 944–949.
97. Shrestha, S., Yang, K., Guy, C., Vogel, P., Neale, G., Chi, H. (2015) Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat. Immunol. 16, 178–187.
98. Huynh, A., DuPage, M., Priyadharshini, B., Sage, P. T., Quiros, J., Borges, C. M., Townamchai, N., Gerriets, V. A., Rathmell, J. C., Sharpe, A. H., Bluestone, J. A., Turka, L. A. (2015) Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16, 188–196.
99. Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., Eltzschig, H. K. (2012) Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc. Natl. Acad. Sci. USA 109, E2784–E2793.
100. Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., Knight, Z. A., Cobb, B. S., Cantrell, D., O’Connor, E., Shokat, K. M., Fisher, A. G., Merkenschlager, M. (2008) T Cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105, 7797–7802.
101. Haxhinasto, S., Mathis, D., Benoist, C. (2008) The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565–574.
102. Liu, G., Burns, S., Huang, G., Boyd, K., Proia, R. L., Flavell, R. A., Chi, H. (2009) The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 10, 769–777.
103. Procaccini, C., De Rosa, V., Galgani, M., Abanni, L., Calì, G., Porcellini, A., Carbone, F., Fontana, S., Horvath, T. L., La Cava, A., Matarese, G. (2010) An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33, 929–941.
104. De Rosa, V., Procaccini, C., Calì, G., Pirozzi, G., Fontana, S., Zappacosta, S., La Cava, A., Matarese, G. (2007) A key role of leptin in the control of regulatory T cell proliferation. Immunity 26, 241–255.
105. Cobbold, S. P., Adams, E., Farquhar, C. A., Nolan, K. F., Howie, D., Lui, K. O., Fairchild, P. J., Mellor, A. L., Ron, D., Waldmann, H. (2009) Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. USA 106, 12055–12060.
106. Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M. L., Puccetti, P. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206–1212.
107. Battaglia, M., Stabilini, A., Roncarolo, M. G. (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105, 4743–4748.
108. Strauss, L., Czystowska, M., Szajnik, M., Mandapathil, M., Whiteside, T. L. (2009) Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. PLoS ONE 4, e5994.
109. Dranoff, G. (2005) The therapeutic implications of intratumoral regulatory T cells. Clin. Cancer Res. 11, 8226–8229.
110. Shafiani, S., Dinh, C., Ertelt, J. M., Moguche, A. O., Siddiqui, I., Smigiel, K. S., Sharma, P., Campbell, D. J., Way, S. S., Urdahl, K. B. (2013) Pathogen-specific Treg cells expand early during Mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. Immunity 38, 1261–1270.
111. McSorley, H. J., Harcus, Y. M., Murray, J., Taylor, M. D., Maizels, R. M. (2008) Expansion of Foxp3+ regulatory T cells in mice infected with the filarial parasite Brugia malayi. J. Immunol. 181, 6456–6466.
112. Carbone, F., De Rosa, V., Carrieri, P. B., Montella, S., Bruzzese, D., Porcellini, A., Procaccini, C., La Cava, A., Matarese, G. (2014) Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat. Med. 20, 69–74.
113. Edozie, F. C., Nova-Lamperti, E. A., Povoleri, G. A., Scottà, C., John, S., Lombardi, G., Afzali, B. (2014) Regulatory T-cell therapy in the induction of transplant tolerance: the issue of subpopulations. Transplantation 98, 370–379.
114. Raimondi, G., Sumpter, T. L., Matta, B. M., Pillai, M., Corbitt, N., Vodovotz, Y., Wang, Z., Thomson, A. W. (2010) Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J. Immunol. 184, 624–636.
115. Issa, F., Wood, K. J. (2014) The potential role for regulatory T-cell therapy in vascularized composite allograft transplantation. Curr. Opin. Organ Transplant. 19, 558–565.
116. Lehtimäki, S., Lahesmaa, R. (2013) Regulatory T cells control immune responses through their non-redundant tissue specific features. Front. Immunol. 4, 294.
117. Zeng, H., Chi, H. (2013) mTOR and lymphocyte metabolism. Curr. Opin. Immunol. 25, 347–355.
118. Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C., Mathis, D. (2012) PPAR-g is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549–553.